 |
|
|
|||||
We own a stock here called Jubilant Pharmova. The company was given a grant from the US government to create a manufacturing facility on the US soil and the US government would have the right of first refusal on production on the facility. And when the US government does not want to source material from that facility, the company is free to manufacture other materials and sell it to whoever they wish to sell.
Category:
News and Media
Vikash Kumar Jain from CLSA discusses India's bullish market trends, potential for low returns, and the recent growth in the pharma sector. He highlights the need not to view global sectors through the India lens and says that will be a blatant mistake. Jain expects increased investment flows into India only after there is rising confidence in emerging markets.
Category:
News and Media
Japanese owner of convenience store giant says offer from Canadian rival grossly undervalues firm.
Category:
News and Media
All news |
||||||||||||||||||
|
||||||||||||||||||